Siglec receptors and hiding plaques in Alzheimer's disease
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease. One hallmark of this disease is the continuous increase in the numbers and size of aggregating amyloid plaques. The accumulation of extracellular plaques is an immunologically interesting phenomenon since microglial cells, brain-specific macrophages, should be able to cleanse the aggregating material from the human brain. Immunotherapy targeting beta-amyloid peptides in plaques with antibodies represents a promising therapy in AD. Recent progress in pattern recognition receptors of monocytes and macrophages has revealed that the sialic acid-binding, immunoglobulin-like lectin (Siglec) family of receptors is an important recognition receptor for sialylated glycoproteins and glycolipids. Interestingly, recent studies have revealed that microglial cells contain only one type of Siglec receptors, Siglec-11, which mediates immunosuppressive signals and thus inhibits the function of other microglial pattern recognition receptors, such as TLRs, NLRs, and RAGE receptors. We will review here the recent literature which clearly indicates that aggregating amyloid plaques are masked in AD by sialylated glycoproteins and gangliosides. Sialylation and glycosylation of plaques, mimicking the cell surface glycocalyx, can activate the immunosuppressive Siglec-11 receptors, as well as hiding the neuritic plaques, allowing them to evade the immune surveillance of microglial cells. This kind of immune evasion can prevent the microglial cleansing process of aggregating amyloid plaques in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, SIGLEC11 and LILRB2 have already been linked to Aβ peptides/amyloid plaques25,26.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [26]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · cited 1×
“The progressive accumulation of extracellular material in affected regions in AD brain is an immunologically interesting observation, since microglial cells, brainspecific macrophages [ 5 ], are present but do not attempt or even seem to be able to clean the aggregating material [6, 7]. On the contrary, the presence o…”
BackgroundSiglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2056 · Cited by 2,031
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
The Structure and Function of the Endothelial Glycocalyx Layer
Weinbaum, S., Tarbell, J. M., & Damiano, E. R. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.151959 · Cited by 1,198
Sialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment
Guillozet, A. L., Weintraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 584
Contribution of glial cells to the development of amyloid plaques in Alzheimer’s disease
Nagele, R. G., Wegiel, J., Venkataraman, V., Imaki, H., Wang, K.-C., & Wegiel, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.01.007 · Cited by 504
Salminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 346
Self-citationMicroglia function in brain tumors
Watters, J. J., Schartner, J. M., & Badie, B. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20485 · Cited by 329
Myelin‐associated glycoprotein (MAG): past, present and beyond
Quarles, R. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04319.x · Cited by 326
Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., & Wilson, M. R. (2007) · The FASEB Journal · doi:10.1096/fj.06-7986com · Cited by 324
Ariga, T., McDonald, M. P., & Yu, R. K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800007-jlr200 · Cited by 318
Malm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301 · cited 1×
“This kind of therapy has shown promising results in Alzheimer's mouse models when it was able to restrict senile plaque formation [ 45 , 46].”
ResultChong, Z. Z., & Maiese, K. (2007) · PubMed · doi:10.14670/hh-22.1251 · Cited by 228
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216 · cited 1×
“Neuritic plaques, also called senile plaques, are large extracellular deposits of β-amyloid fibrils which are associated with a plethora of other material in conjunction with microglial and astrocytic cells [1, 2 ]. Neuritic plaques with their dense core of insoluble material are located in specific brain regions, e.g…”
BackgroundThe microglial phagocytic role with specific plaque types in the Alzheimer disease brain
D’Andrea, M. R., Cole, G. M., & Ard, M. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.026 · Cited by 215 · cited 1×
“The progressive accumulation of extracellular material in affected regions in AD brain is an immunologically interesting observation, since microglial cells, brainspecific macrophages [5], are present but do not attempt or even seem to be able to clean the aggregating material [ 6 , 7]. On the contrary, the presence o…”
BackgroundCloning and Characterization of Human Siglec-11
Angata, T., Kerr, S. C., Greaves, D. R., Varki, N. M., Crocker, P. R., & Varki, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202833200 · Cited by 198
Role of gangliosides in Alzheimer’s disease
Yanagisawa, K. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.018 · Cited by 180
Basic and Clinical Immunology of Siglecs
Von Gunten, S., & Bochner, B. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.011 · Cited by 167
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome
Comelli, E. M., Head, S. R., Gilmartin, T., Whisenant, T., Haslam, S. M., North, S. J., Wong, N.-K., Kudo, T., Narimatsu, H., Esko, J. D., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwj048 · Cited by 167
Wilson, M. R., Yerbury, J. J., & Poon, S. (2007) · Molecular BioSystems · doi:10.1039/b712728f · Cited by 142
Siglecs as positive and negative regulators of the immune system
Crocker, P. R., & Redelinghuys, P. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361467 · Cited by 138
A Human-Specific Gene in Microglia
Hayakawa, T., Angata, T., Lewis, A. L., Mikkelsen, T. S., Varki, N. M., & Varki, A. (2005) · Science · doi:10.1126/science.1114321 · Cited by 130
Iwamoto, N., Nishiyama, E., Ohwada, J., & Arai, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90035-3 · Cited by 129
Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice
Bernardo, A., Harrison, F. E., McCord, M., Zhao, J., Bruchey, A., Davies, S. S., Jackson Roberts, L., Mathews, P. M., Matsuoka, Y., Ariga, T., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.022 · Cited by 127
Gangliosides -- A new therapeutic agent against stroke and Alzheimer's disease
Svennerholm, L. T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00393-9 · Cited by 98
Pathological Proteins in Senile Plaques.
MCGEER, P. L., KLEGERIS, A., WALKER, D. G., YASUHARA, O., & MCGEER, E. G. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.269 · Cited by 93
KALARIA, R. N., GALLOWAY, P. G., & PERRY, G. (1991) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1991.tb00714.x · Cited by 89
β-Amyloid Plaques: Stages in Life History or Independent Origin?
Armstrong, R. A. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017051 · Cited by 84
Glycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human Atherosclerosis
Mukhin, D. N., Chao, F.-F., & Kruth, H. S. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1607 · Cited by 81
Kida, E., Choi-Miura, N.-H., & Wisniewski, K. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00482-6 · Cited by 79
Ganglioside binding pattern of CD33-related siglecs
Rapoport, E. M., Mikhalyov, I. I., Zhang, J., Crocker, P. R., & Bovin, N. V. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00998-8 · Cited by 74
Targeting β-Amyloid Pathology in Alzheimer's Disease with Aβ Immunotherapy
Nitsch, R. M., & Höck, C. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.013 · Cited by 64
Sialic Acid Concentration of Brain Gangliosides: Variation Among Eight Mammalian Species
Wang, B., Brand-Miller, J. C., McNeil, Y., & McVeagh, P. (1998) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(97)00445-5 · Cited by 64
Molecular Cloning and Expression of Human α2,8-Sialyltransferase (hST8Sia V)
Kim, Y., Kim, K.-S., Do, S.-I., Kim, C., Kim, S., & Lee, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6725 · Cited by 60
The Role of Microglia in Antibody-Mediated Clearance of Amyloid-Beta from the Brain
Morgan, D. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601821 · Cited by 58
Martin-Rehrmann, M. D., Hoe, H., Capuani, E. M., & Rebeck, G. W. (2005) · Neurotoxicity Research · doi:10.1007/bf03036452 · Cited by 55
CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease
McMillan, S. J., & Crocker, P. R. (2008) · Carbohydrate Research · doi:10.1016/j.carres.2008.01.009 · Cited by 52
Gangliosides: Their Role in Clinical Neurology
Nobile‐Orazio, E., Carpo, M., & Scarlato, G. (1994) · Drugs · doi:10.2165/00003495-199447040-00002 · Cited by 32
Chava, A. K., Bandyopadhyay, S., Chatterjee, M., & Mandal, C. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000024251.30100.08 · Cited by 30
Nishinaka, T., Iwata, D., Shimada, S., Kosaka, K., & Suzuki, Y. (1993) · Neuroscience Research · doi:10.1016/0168-0102(93)90093-6 · Cited by 21
Iwamoto, N., Suzuki, Y., Makino, Y., Haga, C., Kosaka, K., & Iizuka, R. (1990) · Brain Research · doi:10.1016/0006-8993(90)91592-5 · Cited by 15
P3-169 Investigations of IG-positive neurons in Alzheimer disease tissues
D’Andrea, M. R., & Belkowski, S. M. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)81321-6 · Cited by 9
Clusterin may be involved in rat liver allograft tolerance
Chiang, K. C., Goto, S., Chen, C., Lin, C., Lin, Y., Pan, T., Lord, R. J., Lai, C.-Y., Tseng, H. P., Hsu, L. W., et al. (2000) · Transplant Immunology · doi:10.1016/s0966-3274(00)00011-3 · Cited by 9
The underestimated potential of the immune system in prevention of Alzheimer's disease pathology
Mohajeri, M. H. (2007) · BioEssays · doi:10.1002/bies.20630 · Cited by 7
Rábano, A., Jiménez‐Huete, A., Acevedo, B. E., Calero, M., Ghiso, J. A., Valdés, I., Gavilondo, J., Frangione, B., & Méndez, E. (2005) · Current Alzheimer Research · doi:10.2174/156720505774330500 · Cited by 6
Cited by
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
“Thus, gangliosides may indirectly facilitate the formation and maintenance of amyloid plaques by decreasing clearance through microglial degradatio”
BackgroundGraeber, M. B. (2010) · Science · doi:10.1126/science.1190929 · Cited by 608
Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction
Posse de Chaves, E., & Sipione, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.010 · Cited by 274
“By activating this receptor neuritic plaques would be able to evade the immune surveillance of microglial cells [100].”
BackgroundLipid and Lipoprotein Metabolism in Microglia
Loving, B. A., & Bruce, K. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00393 · Cited by 255
Metadata
- Authors
- Salminen, A., & Kaarniranta, K.
- Affiliations
- University of Eastern Finland (FI)
- Corresponding author
- Salminen, Antero
- Venue
- Journal of Molecular Medicine
- Published
- 2009-04-24
- Volume
- 87
- Issue
- 7
- Pages
- 697-701
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2134422863
- Cited by
- 73
- References
- 47
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 1 · 2013: 5 · 2012: 10
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- Alzheimer's disease, Siglec receptors, amyloid plaques, microglia, immune evasion, sialylation, gangliosides, sialic acid-binding lectins, pattern recognition receptors, amyloid-beta, immunosuppression, glycosylation, neuroinflammation
- MeSH terms
- Alzheimer Disease, Animals, Gangliosides, Glycoproteins, Humans, Models, Biological, Receptors, Immunologic, Lectins, Plaque, Amyloid, Sialic Acid Binding Immunoglobulin-like Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.